Back to MORGAN STANLEY MORGAN STANLEY

ABUSABUS
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in ARBUTUS BIOPHARMA CORP

MORGAN STANLEY holds 17.7M shares of ABUS (ARBUTUS BIOPHARMA CORP), worth $85M as of 2026-Q2. The position was decreased (-31.6% shares). ABUS represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$85M

Current Shares

17.7M

Total Value Change

+$20.2M

Total Shares Change

-3.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
17.7M
-31.6%
$85M0.0%$4.80
0
2026-Q1
Decreased
25.9M
-3.0%
$116.5M0.0%$4.69
0
2025-Q4
Increased
26.7M
+9.2%
$128.4M0.0%$4.62
33
2025-Q3
Increased
24.5M
+1.2%
$111M0.0%$4.46
30
2025-Q2
Increased
24.2M
+1.6%
$74.7M0.0%$3.13
30
2025-Q1
Increased
23.8M
+5.3%
$83M0.0%$3.50
31
2024-Q4
Increased
22.6M
+4.0%
$73.9M0.0%$3.20
31
2024-Q3
Increased
21.7M
+3.6%
$83.6M0.0%$3.83
31
2024-Q2
New
21M
-
$64.8M0.0%$3.09
41

Other major holders of ABUS: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used